(PRESSEMITTEILUNG) PARIS, 4-Jan-2023 — /EuropaWire/ — Sanofi (EPA: SAN), ein globales biopharmazeutisches Unternehmen, das sich auf die menschliche Gesundheit konzentriert, hat bekannt gegeben, dass sein Memorandum für das 4. Quartal 2022 zu Modellierungszwecken jetzt auf der Seite „Investoren“ der Website … Read the full press release
(PRESS RELEASE) STOCKHOLM, 20-Dec-2022 — /EuropaWire/ — EQT, a purpose-driven global investment organization, has announced that its BPEA V Fund will divest Bushu Pharmaceuticals, a leading CMO in Japan that produces high-quality pharmaceutical and medical devices, by selling it to … Read the full press release
Posted in Business, Investment, Management, News, Pharma & Biotech, Sweden
Tagged BPEA EQT, BPEA V Fund, Bushu Pharmaceuticals, CDMO, EQT, Japan, JP Morgan, Kawagoe, KKR, medical devices, Pharmaceutical, pharmaceutical CDMO, Sanwa Kagaku Kenkyusho, Tadao Takano, Tadashi Maruoka, Tetsuichi Okada, Tetsuya Morikawa, Wes Wheeler
(COMMUNIQUÉ DE PRESSE) STOCKHOLM, 20-Dec-2022 — /EuropaWire/ — EQT, une organisation d’investissement mondiale axée sur les objectifs, a annoncé que son fonds BPEA V cèdera Bushu Pharmaceuticals, un chef de file du marketing au Japon qui produit des des dispositifs … Read the full press release
Posted in Business, Investment, Management, Pharma & Biotech, Sweden
Tagged BPEA EQT, BPEA V Fund, Bushu Pharmaceuticals, CDMO, dispositifs médicaux, EQT, Japon, JP Morgan, Kawagoe, KKR, pharmaceutique, pharmaceutique CDMO, Sanwa Kagaku Kenkyusho, Tadao Takano, Tadashi Maruoka, Tetsuichi Okada, Tetsuya Morikawa, Wes Wheeler
The EIB and DeepUll have signed a EUR 20m loan agreement to finance research, development and innovation. The EU financing will enable the development of an automated diagnostics device, leading to faster and more accurate early sepsis diagnosis. The EIB … Read the full press release
Posted in Banks, Financial, Healthcare, Investment, Luxembourg, Pharma & Biotech, Science, Spain, Technology
Tagged acute infections, DeepUll, EIB, European Investment Bank, Horizon 2020, IDFF, InnovFin Infectious Diseases Finance Facility, Jordi Carrera, Mariya Gabriel, medical diagnostics, Ricardo Mourinho Félix, SEPSIS
El BEI y DeepUll han firmado un acuerdo de préstamo de 20 millones de EUR para financiar la investigación, el desarrollo y la innovación. La financiación de la UE permitirá el desarrollo de un dispositivo de diagnóstico automatizado, lo que … Read the full press release
Posted in Banks, Financial, Healthcare, Investment, Pharma & Biotech, Science, Spain, Technology
Tagged Banco Europeo de Inversiones, BEI, DeepUll, diagnóstico médico, Fondo de Financiamiento de Enfermedades Infecciosas InnovFin, Horizonte 2020, IDFF, infecciones agudas, Jordi Carrera, Mariya Gabriel, Ricardo Mourinho Félix, SEPSIS
(PRESS RELEASE) STOCKHOLM, 9-Dec-2022 — /EuropaWire/ — EQT, a purpose-driven global investment organization, has announced that its EQT Future fund, the firm’s new impact-driven longer-hold investment strategy, is co-investing in the SHL Medical, a world-leading provider of drug delivery solutions. … Read the full press release
Posted in Business, Germany, Healthcare, Investment, Management, News, Pharma & Biotech, Sweden, Switzerland
Tagged Andreas Aschenbrenner, ATHOS, autoinjectors, biologic drugs, biosimilar derivatives, Biotech, drug delivery solutions, EQT, EQT Future, Healthcare, life sciences, medical autoinjectors, patient autonomy, Pharmaceutical, Rikke Kjær Nielsen, Roger Samuelsson, SHL Medical, Ulrich Faessler, Wolfgang Essler
(COMMUNIQUÉ DE PRESSE) STOCKHOLM, 9-Dec-2022 — /EuropaWire/ — EQT, une organisation d’investissement mondiale axée sur les objectifs, a annoncé que son fonds EQT Future, la nouvelle stratégie d’investissement à long terme axée sur l’impact, est co-investissant dans SHL Medical, l’un … Read the full press release
Posted in Business, Germany, Healthcare, Industrial, Investment, Pharma & Biotech, Sweden, Switzerland
Tagged Andreas Aschenbrenner, ATHOS, Auto-injecteurs, auto-injecteurs médicaux, autonomie du patient, biotechnologie, dérivés biosimilaires, EQT, EQT Future, médicaments biologiques, pharmaceutique, Rikke Kjær Nielsen, Roger Samuelsson, Santé, sciences de la vie, SHL Medical, solutions d'administration de médicaments, Ulrich Faessler, Wolfgang Essler
The company announces FDA clearance for its Alzheimer’s disease Cerebrospinal Fluid (CSF) assays The Elecsys® Alzheimer’s disease (AD) CSF assays will be available on the cobas fully automated immunoassay analyzers, enabling patients to get broad access to high quality testing in a timely … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged Alzheimer, beta-amyloid, biomarkers t, CT scan, diagnosis, Elecsys AD CSF Abeta42, Elecsys AD CSF assays, FDA, MRI, pTau181 assays, Roche, tau proteins, Thomas Schinecker
La compañía anuncia la aprobación de la FDA para sus ensayos de líquido cefalorraquídeo (LCR) para la enfermedad de Alzheimer Los ensayos Elecsys® para la enfermedad de Alzheimer (EA) en LCR estarán disponibles en los analizadores de inmunoensayo totalmente automatizados … Read the full press release
Posted in Business, Healthcare, Pharma & Biotech, Science, Switzerland, Technology
Tagged Alzheimer, beta-amiloide, biomarcadores t, Diagnóstico, Elecsys AD CSF Abeta42, Elecsys Ensayos AD LCR, Elecsys® beta-amiloide, Elecsys® Phospho-Tau, FDA, patología de Alzheimer, proteínas tau, pTau181 ensayos, resonancia magnética, Roche, Thomas Schinecker, tomografía computarizada
(PRESS RELEASE) CAMBRIDGE, 2-Nov-2022 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British-Swedish multinational pharmaceutical and biotechnology company, has announced fully funded postdoctoral research positions for the six winners at its R&D Postdoctoral Challenge announced earlier this year. The research positions … Read the full press release
(PRESSEMITTEILUNG) CAMBRIDGE, 2-Nov-2022 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), ein britisch-schwedisches multinationales Unternehmen Pharma- und Biotechnologieunternehmen, hat voll finanzierte Postdoktoranden-Forschungsstellen für die sechs Gewinner in seinem R&D Postdoctoral Challenge früher in diesem Jahr angekündigt. Die Forschungspositionen werden für zwei Jahre … Read the full press release
Posted in Education, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AstraZeneca, Biopharmazie, Prof. Sir Mene Pangalos, R&D Postdoctoral Challenge
The cobas SARS-CoV-2 Qualitative test is one of the first COVID-19 PCR tests performed on an automated, high throughput platform to receive FDA 510(k) clearance. This FDA clearance will ensure that the healthcare community has access to timely, reliable and accurate COVID-19 PCR testing … Read the full press release
Le test qualitatif cobas SARS-CoV-2 est l’un des premiers tests PCR COVID-19 effectués sur une plateforme automatisée à haut débit à recevoir l’autorisation FDA 510(k). Cette autorisation de la FDA garantira que la communauté des soins de santé a accès … Read the full press release
4 million1 hours of hypoglycemia avoided Trust in the algorithm leads to fewer meal declarations Users report a significantly reduced mental load (PRESS RELEASE) PARIS, 21-Sep-2022 — /EuropaWire/ — Diabeloop, a leader in therapeutic AI applied to insulin delivery, reports … Read the full press release
Posted in Denmark, France, Healthcare, News, Pharma & Biotech, Science, Sweden, Technology
Tagged #dedoc, automated insulin delivery, DBL-4pen, DBL-hu, DBLG1, Diabeloop, Diabetes, EASD, EASD Annual Meeting 2022, EASD2022, Erik Huneker, hybrid closed-loop system, Hypoglycemia, insulin delivery, Pr. Lutz Heinemann, Pr. Pierre-Yves Benhamou, Stéphanie JEGU, therapeutic AI, Time In Range, type 1 diabetes
(PRESS RELEASE) PARIS, 13-Sep-2022 — /EuropaWire/ — LGT Capital Partners Ltd., a leading alternative investment specialist with over USD 85 billion in assets under management, has announced that LGT Private Debt, its private debt competence center focused on arranging and … Read the full press release
(COMMUNIQUÉ DE PRESSE) PARIS, 13-Sep-2022 — /EuropaWire/ — LGT Capital Partners Ltd., l’un des principaux spécialistes de l’investissement alternatif avec plus de 85 milliards de dollars d’actifs sous gestion, a annoncé que LGT Private Debt, son centre de compétences en dette … Read the full press release
(PRESS RELEASE) HOERSHOLM, Denmark, 12-Sep-2022 — /EuropaWire/ — Chr Hansen Holding A/S (CPH: CHR), a Danish bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries, has announced new regulatory approvals around the world for … Read the full press release
Posted in Denmark, Food & Beverage, Healthcare, Pharma & Biotech, Science
Tagged 2’-FL, 2’-fucosyllactose, 3-FL, 3-fucosyllactose, 3’-sialyllactose, 3’-SL, 6’-sialyllactose, 6’-SL, breast milk, breastfeeding, Chr. Hansen, EFSA, European Food Safety Authority, FDA, Generally Recognized as Safe, GRAS, hepatology, HMOs, Human Milk Oligosaccharides, infant formula, infant health, infant microbiome science, Jesper Sig Mathiasen, lacto-N-tetraose, LNT, NASPGHAN 2022, Novel Food approval, Nutrition, pediatric gastroenterologists, pediatric gastroenterology, WHO, World Health Organization
(PRESSEMITTEILUNG) HOERSHOLM, Denmark, 12-Sep-2022 — /EuropaWire/ — Chr Hansen Holding A/S (CPH: CHR), ein Däne Biowissenschaftsunternehmen, das Lösungen für natürliche Inhaltsstoffe für die Lebensmittel-, Ernährungs-, Pharma- und Landwirtschaftsindustrie entwickelt, hat weltweit neue behördliche Zulassungen für seine Humanmilch-Oligosaccharide für Säuglingsanfangsnahrung bekannt … Read the full press release
Ad hoc announcement pursuant to Art. 53 LR (PRESS RELEASE) BASEL/ ALLSCHWIL, 7-Sep-2022 — /EuropaWire/ — Basilea Pharmaceutica Ltd (SWX: BSLN), a commercial stage biopharmaceutical company, has announced the company has secured non-dilutive refinancing in the amount of CHF 75 … Read the full press release
Annonce ad hoc conformément à l’art. 53LR (COMMUNIQUÉ DE PRESSE) BASEL/ ALLSCHWIL, 7-Sep-2022 — /EuropaWire/ — Basilea Pharmaceutica Ltd (SWX : BSLN), une société biopharmaceutique au stade commercial, a annoncé la La société a obtenu un refinancement non dilutif d’un montant … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?